Alterity Therapeutics

ATHE

Market cap $85.2M

ATHE Hedge Fund Activity: Q1 2026 in Review

15 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2026, worth a combined $1.12M — up 12% from $1M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ATHE and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, adding an estimated $11.1K. The largest seller was Morgan Stanley, cutting an estimated $18K.

• 15 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2026, down from 18 in Q4 2025.
• Funds reported $1.12M of Alterity Therapeutics stock for Q1 2026, up 12% quarter-over-quarter.
• 0 funds opened new Alterity Therapeutics positions in Q1 2026 and 2 closed out, a net change of -2 holders.
• The largest Alterity Therapeutics buyer in Q1 2026 was Citadel Advisors, an estimated $11.1K added.
• The largest Alterity Therapeutics seller in Q1 2026 was Morgan Stanley, an estimated $18K sold.

Based on aggregated 13F filings for Q1 2026.